Quality of care before and after initial certification at a German certified hereditary breast and ovarian cancer center
Certification of medical institutions ensures high-quality, evidence-based patient care and increases the utilization of preventive and counseling services, particularly for Hereditary Breast and Ovarian Cancer. Further studies are needed to confirm the long-term impact and necessity of certification.
Authors
- Carolin C. Hack (ORCID: https://orcid.org/0000-0002-2426-7020)
- Carolin Müller (ORCID: https://orcid.org/0000-0003-3488-5073)
- Simon Bader
- Felix Heindl (ORCID: https://orcid.org/0000-0002-5484-2575)
- Annika Krückel (ORCID: https://orcid.org/0009-0007-3298-9238)
- Lena M. Brückner
- Peter A. Fasching (ORCID: https://orcid.org/0000-0003-1709-1079)
- Matthias W. Beckmann
- Niklas Amann (ORCID: https://orcid.org/0009-0005-5280-2800)
- Julia Gocke
- Manuel Hörner (ORCID: https://orcid.org/0000-0001-6934-992X)
- Henrik Spannring
- Cornelia Boesl
Institutions
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- LMU Klinikum (DE)
- Comprehensive Cancer Center Erlangen (DE)
- Ludwig-Maximilians-Universität München (DE)
Publication Details
- Journal
- Journal of Cancer Research and Clinical Oncology
- Published
- 2025-12-17
- DOI
- https://doi.org/10.1007/s00432-025-06388-3
- Primary Topic
- BRCA gene mutations in cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00